Finally, this darapladib meta-analysis represents one of the largest PGx studies ever conducted, providing a large pool of data with comprehensive data mining opportunities, to further the understanding of the mechanism of action of Lp-PLA2 inhibitors and CHD disease genetics. This evidence concerns the gene PLA2G7 and coronary artery disorder.